Regeneron Pharmaceuticals Inc. partners with Fujifilm Diosynth Biotechnologies in a $3 billion deal to enhance US production of biologic medicines, with total investments in produc...
Regeneron Pharmaceuticals Inc. announces a $3 billion partnership with Fujifilm Diosynth Biotechnologies to boost biologic medicine production in North Carolina, alongside a $7 bil...
Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have signed a $3 billion deal to produce biologic medicines in North Carolina, marking a significant investment...
Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have entered a $3 billion agreement to produce biologic medicines in North Carolina, marking a significant step...
Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have announced a $3 billion partnership to enhance the production of biologic medicines in the US, with additio...
Regeneron Pharmaceuticals Inc. and Fujifilm Diosynth Biotechnologies have announced a $3 billion deal to produce biologic medicines in North Carolina, marking a significant step in...
